Brown Advisory Inc Takeda Pharmaceutical CO LTD Transaction History

Brown Advisory Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$16.55 - $18.64 $177,697 - $200,137	-10,737 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$16.71 - $19.9 $3,559 - $4,238	213 Added 2.02%	10,737 $196,000
Q4 2020 Feb 12, 2021	BUY	$15.39 - $18.97 $161,964 - $199,640	10,524 New	10,524 $191,000
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $814,686 - $907,505	-50,445 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$16.58 - $20.49 $33,408 - $41,287	2,015 Added 4.16%	50,445 $893,000

Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $808,781 - $1.04 Million	48,430 New	48,430 $986,000

338

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.